nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—PTGS1—Etoposide—muscle cancer	0.264	0.332	CbGbCtD
Zileuton—CYP1A2—Dacarbazine—muscle cancer	0.241	0.303	CbGbCtD
Zileuton—CYP1A2—Etoposide—muscle cancer	0.118	0.148	CbGbCtD
Zileuton—CYP3A4—Vincristine—muscle cancer	0.0673	0.0849	CbGbCtD
Zileuton—CYP3A4—Etoposide—muscle cancer	0.0617	0.0778	CbGbCtD
Zileuton—CYP3A4—Doxorubicin—muscle cancer	0.0421	0.0531	CbGbCtD
Zileuton—Chronic liver disease—Methotrexate—muscle cancer	0.0279	0.172	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—muscle cancer	0.0103	1	CrCbGaD
Zileuton—Hepatotoxicity—Dactinomycin—muscle cancer	0.006	0.0371	CcSEcCtD
Zileuton—Hepatotoxicity—Etoposide—muscle cancer	0.00434	0.0268	CcSEcCtD
Zileuton—LTB4R—bone marrow—muscle cancer	0.00369	0.106	CbGeAlD
Zileuton—LTB4R—vagina—muscle cancer	0.00354	0.102	CbGeAlD
Zileuton—UGT1A9—renal system—muscle cancer	0.00329	0.0945	CbGeAlD
Zileuton—LTB4R—testis—muscle cancer	0.00316	0.0907	CbGeAlD
Zileuton—Liver disorder—Methotrexate—muscle cancer	0.00294	0.0182	CcSEcCtD
Zileuton—EPHX2—tendon—muscle cancer	0.00281	0.0806	CbGeAlD
Zileuton—EPHX2—vagina—muscle cancer	0.0026	0.0748	CbGeAlD
Zileuton—Hepatotoxicity—Methotrexate—muscle cancer	0.0026	0.0161	CcSEcCtD
Zileuton—Hepatitis—Dactinomycin—muscle cancer	0.00233	0.0144	CcSEcCtD
Zileuton—EPHX2—testis—muscle cancer	0.00232	0.0668	CbGeAlD
Zileuton—ALOX5—smooth muscle tissue—muscle cancer	0.00224	0.0643	CbGeAlD
Zileuton—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.00221	0.0137	CcSEcCtD
Zileuton—Liver injury—Doxorubicin—muscle cancer	0.00207	0.0128	CcSEcCtD
Zileuton—Vaginal inflammation—Methotrexate—muscle cancer	0.00201	0.0124	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.00191	0.0118	CcSEcCtD
Zileuton—Vaginal infection—Methotrexate—muscle cancer	0.0019	0.0117	CcSEcCtD
Zileuton—Ill-defined disorder—Dactinomycin—muscle cancer	0.00188	0.0116	CcSEcCtD
Zileuton—Jaundice—Etoposide—muscle cancer	0.00183	0.0113	CcSEcCtD
Zileuton—Malaise—Dactinomycin—muscle cancer	0.00183	0.0113	CcSEcCtD
Zileuton—Neck pain—Doxorubicin—muscle cancer	0.00176	0.0109	CcSEcCtD
Zileuton—Vaginal inflammation—Doxorubicin—muscle cancer	0.00174	0.0108	CcSEcCtD
Zileuton—Myalgia—Dactinomycin—muscle cancer	0.00172	0.0107	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—muscle cancer	0.00171	0.0106	CcSEcCtD
Zileuton—Discomfort—Dactinomycin—muscle cancer	0.0017	0.0105	CcSEcCtD
Zileuton—Vaginal infection—Doxorubicin—muscle cancer	0.00164	0.0102	CcSEcCtD
Zileuton—ALOX5—bone marrow—muscle cancer	0.00163	0.0468	CbGeAlD
Zileuton—Myalgia—Vincristine—muscle cancer	0.00154	0.00953	CcSEcCtD
Zileuton—Hypertonia—Doxorubicin—muscle cancer	0.00152	0.00943	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00151	0.00931	CcSEcCtD
Zileuton—Lymphadenopathy—Doxorubicin—muscle cancer	0.00148	0.00915	CcSEcCtD
Zileuton—ALOX5—head—muscle cancer	0.00144	0.0414	CbGeAlD
Zileuton—Pain—Dactinomycin—muscle cancer	0.00141	0.00874	CcSEcCtD
Zileuton—ALOX5—testis—muscle cancer	0.00139	0.04	CbGeAlD
Zileuton—Feeling abnormal—Dactinomycin—muscle cancer	0.00136	0.00842	CcSEcCtD
Zileuton—Ill-defined disorder—Etoposide—muscle cancer	0.00136	0.00841	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00134	0.00832	CcSEcCtD
Zileuton—Insomnia—Vincristine—muscle cancer	0.00133	0.00826	CcSEcCtD
Zileuton—Malaise—Etoposide—muscle cancer	0.00132	0.00817	CcSEcCtD
Zileuton—Body temperature increased—Dactinomycin—muscle cancer	0.00131	0.00808	CcSEcCtD
Zileuton—Gastrointestinal disorder—Vincristine—muscle cancer	0.00127	0.00788	CcSEcCtD
Zileuton—Pain—Vincristine—muscle cancer	0.00126	0.00781	CcSEcCtD
Zileuton—Constipation—Vincristine—muscle cancer	0.00126	0.00781	CcSEcCtD
Zileuton—Chest pain—Etoposide—muscle cancer	0.00125	0.00772	CcSEcCtD
Zileuton—Discomfort—Etoposide—muscle cancer	0.00123	0.00762	CcSEcCtD
Zileuton—Hypersensitivity—Dactinomycin—muscle cancer	0.00122	0.00753	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00117	0.00724	CcSEcCtD
Zileuton—Body temperature increased—Vincristine—muscle cancer	0.00117	0.00722	CcSEcCtD
Zileuton—Abdominal pain upper—Doxorubicin—muscle cancer	0.00115	0.00713	CcSEcCtD
Zileuton—Diarrhoea—Dactinomycin—muscle cancer	0.00113	0.00699	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—muscle cancer	0.00109	0.00675	CcSEcCtD
Zileuton—Hypersensitivity—Vincristine—muscle cancer	0.00109	0.00673	CcSEcCtD
Zileuton—Somnolence—Etoposide—muscle cancer	0.00106	0.00658	CcSEcCtD
Zileuton—Vomiting—Dactinomycin—muscle cancer	0.00105	0.0065	CcSEcCtD
Zileuton—Rash—Dactinomycin—muscle cancer	0.00104	0.00644	CcSEcCtD
Zileuton—Gastrointestinal disorder—Etoposide—muscle cancer	0.00103	0.00639	CcSEcCtD
Zileuton—Constipation—Etoposide—muscle cancer	0.00102	0.00633	CcSEcCtD
Zileuton—Pain—Etoposide—muscle cancer	0.00102	0.00633	CcSEcCtD
Zileuton—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00101	0.00627	CcSEcCtD
Zileuton—Diarrhoea—Vincristine—muscle cancer	0.00101	0.00625	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—muscle cancer	0.00101	0.00624	CcSEcCtD
Zileuton—CYP1A2—renal system—muscle cancer	0.000998	0.0287	CbGeAlD
Zileuton—Feeling abnormal—Etoposide—muscle cancer	0.000985	0.0061	CcSEcCtD
Zileuton—Nausea—Dactinomycin—muscle cancer	0.000981	0.00607	CcSEcCtD
Zileuton—Dizziness—Vincristine—muscle cancer	0.000976	0.00604	CcSEcCtD
Zileuton—Urticaria—Etoposide—muscle cancer	0.00095	0.00588	CcSEcCtD
Zileuton—Jaundice—Doxorubicin—muscle cancer	0.000948	0.00586	CcSEcCtD
Zileuton—Body temperature increased—Etoposide—muscle cancer	0.000945	0.00585	CcSEcCtD
Zileuton—Urinary tract infection—Doxorubicin—muscle cancer	0.000945	0.00585	CcSEcCtD
Zileuton—Conjunctivitis—Doxorubicin—muscle cancer	0.000945	0.00585	CcSEcCtD
Zileuton—Vomiting—Vincristine—muscle cancer	0.000938	0.00581	CcSEcCtD
Zileuton—Rash—Vincristine—muscle cancer	0.000931	0.00576	CcSEcCtD
Zileuton—Dermatitis—Vincristine—muscle cancer	0.00093	0.00575	CcSEcCtD
Zileuton—Headache—Vincristine—muscle cancer	0.000925	0.00572	CcSEcCtD
Zileuton—Sinusitis—Doxorubicin—muscle cancer	0.000912	0.00564	CcSEcCtD
Zileuton—PTGS1—smooth muscle tissue—muscle cancer	0.000898	0.0258	CbGeAlD
Zileuton—Hypersensitivity—Etoposide—muscle cancer	0.000881	0.00545	CcSEcCtD
Zileuton—Nausea—Vincristine—muscle cancer	0.000877	0.00542	CcSEcCtD
Zileuton—Hepatitis—Doxorubicin—muscle cancer	0.000873	0.0054	CcSEcCtD
Zileuton—PTGS1—renal system—muscle cancer	0.000865	0.0248	CbGeAlD
Zileuton—Pruritus—Etoposide—muscle cancer	0.000846	0.00523	CcSEcCtD
Zileuton—Diarrhoea—Etoposide—muscle cancer	0.000818	0.00506	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—muscle cancer	0.000814	0.00504	CcSEcCtD
Zileuton—Malaise—Methotrexate—muscle cancer	0.000791	0.0049	CcSEcCtD
Zileuton—Dizziness—Etoposide—muscle cancer	0.000791	0.00489	CcSEcCtD
Zileuton—PTGS1—cardiac atrium—muscle cancer	0.000774	0.0222	CbGeAlD
Zileuton—Vomiting—Etoposide—muscle cancer	0.00076	0.0047	CcSEcCtD
Zileuton—Rash—Etoposide—muscle cancer	0.000754	0.00466	CcSEcCtD
Zileuton—Dermatitis—Etoposide—muscle cancer	0.000753	0.00466	CcSEcCtD
Zileuton—Headache—Etoposide—muscle cancer	0.000749	0.00463	CcSEcCtD
Zileuton—Flatulence—Doxorubicin—muscle cancer	0.000749	0.00463	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—muscle cancer	0.000747	0.00462	CcSEcCtD
Zileuton—Myalgia—Methotrexate—muscle cancer	0.000747	0.00462	CcSEcCtD
Zileuton—Chest pain—Methotrexate—muscle cancer	0.000747	0.00462	CcSEcCtD
Zileuton—Tension—Doxorubicin—muscle cancer	0.000746	0.00461	CcSEcCtD
Zileuton—Discomfort—Methotrexate—muscle cancer	0.000738	0.00457	CcSEcCtD
Zileuton—Nervousness—Doxorubicin—muscle cancer	0.000738	0.00457	CcSEcCtD
Zileuton—CYP3A4—renal system—muscle cancer	0.000722	0.0208	CbGeAlD
Zileuton—Nausea—Etoposide—muscle cancer	0.00071	0.00439	CcSEcCtD
Zileuton—Ill-defined disorder—Doxorubicin—muscle cancer	0.000705	0.00436	CcSEcCtD
Zileuton—Malaise—Doxorubicin—muscle cancer	0.000685	0.00424	CcSEcCtD
Zileuton—PTGS1—tendon—muscle cancer	0.000675	0.0194	CbGeAlD
Zileuton—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000652	0.00404	CcSEcCtD
Zileuton—Insomnia—Methotrexate—muscle cancer	0.000648	0.00401	CcSEcCtD
Zileuton—Myalgia—Doxorubicin—muscle cancer	0.000647	0.004	CcSEcCtD
Zileuton—Chest pain—Doxorubicin—muscle cancer	0.000647	0.004	CcSEcCtD
Zileuton—Arthralgia—Doxorubicin—muscle cancer	0.000647	0.004	CcSEcCtD
Zileuton—Discomfort—Doxorubicin—muscle cancer	0.000639	0.00395	CcSEcCtD
Zileuton—Somnolence—Methotrexate—muscle cancer	0.000637	0.00394	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—muscle cancer	0.00063	0.0039	CcSEcCtD
Zileuton—PTGS1—vagina—muscle cancer	0.000626	0.018	CbGeAlD
Zileuton—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000618	0.00383	CcSEcCtD
Zileuton—Pain—Methotrexate—muscle cancer	0.000612	0.00379	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—muscle cancer	0.00059	0.00365	CcSEcCtD
Zileuton—PTGS1—head—muscle cancer	0.000578	0.0166	CbGeAlD
Zileuton—Urticaria—Methotrexate—muscle cancer	0.000569	0.00352	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—muscle cancer	0.000566	0.0035	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000565	0.0035	CcSEcCtD
Zileuton—Insomnia—Doxorubicin—muscle cancer	0.000561	0.00347	CcSEcCtD
Zileuton—PTGS1—testis—muscle cancer	0.000559	0.0161	CbGeAlD
Zileuton—Somnolence—Doxorubicin—muscle cancer	0.000551	0.00341	CcSEcCtD
Zileuton—Dyspepsia—Doxorubicin—muscle cancer	0.000546	0.00338	CcSEcCtD
Zileuton—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000535	0.00331	CcSEcCtD
Zileuton—Pain—Doxorubicin—muscle cancer	0.00053	0.00328	CcSEcCtD
Zileuton—Constipation—Doxorubicin—muscle cancer	0.00053	0.00328	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—muscle cancer	0.000528	0.00326	CcSEcCtD
Zileuton—Feeling abnormal—Doxorubicin—muscle cancer	0.000511	0.00316	CcSEcCtD
Zileuton—Pruritus—Methotrexate—muscle cancer	0.000507	0.00313	CcSEcCtD
Zileuton—Urticaria—Doxorubicin—muscle cancer	0.000493	0.00305	CcSEcCtD
Zileuton—Body temperature increased—Doxorubicin—muscle cancer	0.00049	0.00303	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—muscle cancer	0.00049	0.00303	CcSEcCtD
Zileuton—Dizziness—Methotrexate—muscle cancer	0.000474	0.00293	CcSEcCtD
Zileuton—Hypersensitivity—Doxorubicin—muscle cancer	0.000457	0.00283	CcSEcCtD
Zileuton—Vomiting—Methotrexate—muscle cancer	0.000455	0.00282	CcSEcCtD
Zileuton—Rash—Methotrexate—muscle cancer	0.000452	0.00279	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—muscle cancer	0.000451	0.00279	CcSEcCtD
Zileuton—Headache—Methotrexate—muscle cancer	0.000449	0.00278	CcSEcCtD
Zileuton—Pruritus—Doxorubicin—muscle cancer	0.000439	0.00271	CcSEcCtD
Zileuton—Nausea—Methotrexate—muscle cancer	0.000425	0.00263	CcSEcCtD
Zileuton—Diarrhoea—Doxorubicin—muscle cancer	0.000424	0.00262	CcSEcCtD
Zileuton—Dizziness—Doxorubicin—muscle cancer	0.00041	0.00254	CcSEcCtD
Zileuton—Vomiting—Doxorubicin—muscle cancer	0.000394	0.00244	CcSEcCtD
Zileuton—Rash—Doxorubicin—muscle cancer	0.000391	0.00242	CcSEcCtD
Zileuton—Dermatitis—Doxorubicin—muscle cancer	0.000391	0.00242	CcSEcCtD
Zileuton—Headache—Doxorubicin—muscle cancer	0.000388	0.0024	CcSEcCtD
Zileuton—Nausea—Doxorubicin—muscle cancer	0.000368	0.00228	CcSEcCtD
